Skip to main content

Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy

A biotech company focused on early cancer screening and detection has formed a wholly owned subsidiary that is developing a food trade and delivery platform for local restaurants and supermarkets.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.